Money moves: How the biotech market is weathering inflationary storms
Kickstarting the Money Moves series, Pharmaceutical Technology looks at what the biotech market holds for 2023.
IPO Industry
Valneva receives up to £20m vaccine R&D funding in Scotland
Covid-19 update: Yellen calls for new fund to tackle future health crises
Ventus Therapeutics raises funding to expedite drug discovery platform
Macro view: Covid-19 response did not lack funding
PharmaLex enters merger deal with Ascent Development Services
UCB enhances epilepsy portfolio with Zogenix acquisition
Over $1bn raised in venture capital funding for gene editing in 2021
